12 min listen
PDS Biotech (PDSB) Overview: Cancer Immunotherapies
FromSchwab Network
ratings:
Length:
5 minutes
Released:
Jun 17, 2021
Format:
Podcast episode
Description
PDS Biotech (PDSB) is a clinical-stage immunotherapy company that has a growing pipeline of cancer immunotherapies and infectious disease vaccines. Frank Bedu-Addo, President and CEO of PDS Biotech, gives an overview of PDS Biotech, highlighting its new cancer drug, Versamune, which effectively delivers disease-specific antigens for in vivo uptake and processing. Tune in to find out more.
Released:
Jun 17, 2021
Format:
Podcast episode
Titles in the series (100)
Zoom (ZM) CFO Talks Earnings & Place In The Work From Home Culture by Schwab Network